# Liminatus Pharma, Inc.: Form 8-K, filed Aug 4, 2026

- Company: [Liminatus Pharma, Inc.](/companies/limn.md) (CIK 1971387)
- Form: 8-K
- Filed: 2026-08-04
- Accepted by EDGAR: Aug 4, 2026, 16:30 ET
- Period: 2026-08-03
- Accession: 0001104659-26-090423
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1971387/000110465926090423/tm2622207d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971387/000110465926090423/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971387/000110465926090423/tm2622207d1_8k.htm

Filed Aug 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-090423. Last ingested by Listed: Nov 3, 2026, 19:32 ET. No prices; not investment advice.
